<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Interactive diabetes case 13: Deterioration of glycemia in a 59-year-old patient with type 2 diabetes complicated by retinopathy, nephropathy, and neuropathy – Comment</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Interactive diabetes case 13: Deterioration of glycemia in a 59-year-old patient with type 2 diabetes complicated by retinopathy, nephropathy, and neuropathy – Comment</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Interactive diabetes case 13: Deterioration of glycemia in a 59-year-old patient with type 2 diabetes complicated by retinopathy, nephropathy, and neuropathy – Comment</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lloyd Axelrod, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">COMMENT</span><span class="headingEndMark"> — </span>Diabetic gastroparesis is a manifestation of autonomic neuropathy. It occurs in patients with both type 1 and type 2 diabetes, typically in the setting of other microvascular complications such as retinopathy, nephropathy, and other forms of diabetic neuropathy. The patient typically presents with nausea, vomiting, early satiety, abdominal bloating or fullness, abdominal pain, and deterioration of glycemia. The vomited material may contain food that was consumed a long time before the episode, often 12 hours to a few days earlier. The delay in gastric emptying results in delayed and unpredictable delivery of nutrients from the stomach to the small intestine, leading to variable glucose absorption and fluctuating glucose levels. Diabetic gastroparesis should be considered in any patient in whom diabetes management has deteriorated without other explanation and after careful review of diet and physical activity. Restoration of glycemic management requires treatment of the gastroparesis. The use of an intensive insulin regimen or an insulin pump is not likely to be effective until the gastroparesis is controlled, because the variable glucose absorption confounds efforts to calculate a true "prandial" dose.</p><p>The patient's medications should be reviewed to identify any agent or agents known to impair gastrointestinal (GI) motility including narcotics, anticholinergic agents, glucagon-like peptide 1 (GLP-1) receptor agonists, amylin analogs, and <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">cyclosporine</a>. An upper GI series is often helpful to rule out obstruction and for the evaluation of other common upper GI problems, especially gastroesophageal reflux, which may coexist in patients with diabetic gastroparesis. Intestinal obstruction should always be ruled out.</p><p>Several tests are recommended for the evaluation of the patient suspected of having diabetic gastroparesis, including radionuclide gastric emptying studies, radiolabeled breath tests, and wireless motility capsules. The availability and use of these procedures vary from one institution to another, although a consensus recommendation has been published [<a href="#rid1">1</a>]. While studies using optimal gastric emptying test methods demonstrate significant associations between abnormal results and symptoms, the recommended tests are complex and difficult to execute properly. The available studies are insufficient to provide recommendations for patients with diabetes [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/2640.html" rel="external">"Gastroparesis: Etiology, clinical manifestations, and diagnosis"</a>.)</p><p>Consequently, a therapeutic trial of a prokinetic agent is often the appropriate diagnostic and therapeutic choice. <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">Metoclopramide</a>, a dopamine antagonist, is the prokinetic agent of choice in the United States. The usual starting dose is 5 mg by mouth 15 minutes before meals and at bedtime, preferably as a liquid formulation, with plans to titrate the dose up to 40 mg a day as needed and as tolerated. Typical side effects of metoclopramide include drowsiness, restlessness, dystonia, tardive dyskinesia, and Parkinson syndrome. Reductions in dose are necessary in patients with kidney insufficiency. Patients with gastroparesis may not absorb oral metoclopramide predictably due to the delayed gastric emptying and other alterations in GI motility. When oral metoclopramide has failed after an adequate trial of appropriate doses for at least two weeks, subcutaneous or intravenous metoclopramide may be tried for 10 to 14 days. These parenteral routes assure adequate bioavailability. When symptoms subside, the patient's treatment can be changed to oral metoclopramide, which may then be absorbed well enough to sustain the response. One should avoid treatment with metoclopramide for more than 12 weeks because of the increased risk of developing tardive dyskinesia with longer-term use.</p><p>Attention to diet is essential. A program of frequent small meals with soft solids and a low-fat diet without undigestible fiber is often helpful. Liquid nutritional supplements may also be useful in selected cases. <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">Parenteral nutrition</a> is needed only on rare occasions.</p><p>Most patients will respond to diet and <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a>. Patients who do not respond are difficult to manage. Other prokinetic agents are sometimes used, including oral (preferably as a liquid formulation) or intravenous <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a>. This agent may improve motility and symptoms but may also cause abdominal pain and other GI symptoms, so the net benefit of its use is not clear. <a class="drug drug_general" data-topicid="8777" href="/z/d/drug information/8777.html" rel="external">Domperidone</a> and <a class="drug drug_general" data-topicid="9269" href="/z/d/drug information/9269.html" rel="external">cisapride</a>, other prokinetic agents, are not available on the market in the United States, because of adverse cardiovascular side effects including ventricular arrhythmias. They are available in some other countries. (See  <a class="medical medical_review" href="/z/d/html/2532.html" rel="external">"Treatment of gastroparesis"</a>.)</p><p>Surgical procedures are of no proven benefit. They may worsen the patient's symptoms.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103:753.</a></li><li><a class="nounderline abstract_t">Vijayvargiya P, Jameie-Oskooei S, Camilleri M, et al. Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis. Gut 2019; 68:804.</a></li></ol></div><div id="topicVersionRevision">Topic 4220 Version 8.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18028513" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29860241" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
